You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AHCT

Showing 1 - 25 of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT

Not yet recruiting
  • Multiple Myeloma
  • Dara-VRd intensification, Dara-R maintenance
  • +4 more
  • (no location specified)
Dec 13, 2022

Multiple Myeloma Trial in Cleveland (Evomela, Next Generation Sequencing, Prochlorperazine)

Not yet recruiting
  • Multiple Myeloma
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Apr 19, 2022

Multiple Myeloma Trial in United States (Iberdomide, Daratumumab, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Durham, North Carolina
  • +5 more
Jun 22, 2022

Multiple Myeloma Trial in United States (Plinabulin)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Jun 17, 2022

Multiple Myeloma Trial in United States (Iberdomide)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +7 more
Jun 10, 2022

Recurrent Adult Hodgkin Lymphoma Trial in Duarte (biological, drug, other, procedure)

Active, not recruiting
  • Recurrent Adult Hodgkin Lymphoma
  • basiliximab
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial in United States (Romiplostim)

Active, not recruiting
  • Multiple Myeloma
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Mar 7, 2022

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Basiliximab, Carmustine, Cytarabine)

Recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Basiliximab
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Jun 16, 2022

Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in United States (AB-205, Placebo)

Recruiting
  • Hodgkin Lymphoma
  • Non Hodgkin Lymphoma
  • AB-205
  • Placebo
  • Duarte, California
  • +20 more
Aug 2, 2022

Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)

Recruiting
  • Lymphoma
  • +4 more
  • Pharmacokinetics
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 12, 2022

Multiple Myeloma Trial in Birmingham (DaraVRD)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
    University of Alabama at Birmingham
Oct 20, 2021

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other, biological)

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Duarte, California
  • +3 more
Oct 24, 2022

Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Myeloma-Associated Amyloidosis
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 6, 2023

Multiple Myeloma Trial in New York (Ide-cel (bb2121))

Recruiting
  • Multiple Myeloma
  • Ide-cel (bb2121)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 6, 2022

Multiple Myeloma, Amyloidosis Trial in New York (device, drug, procedure)

Active, not recruiting
  • Multiple Myeloma
  • Amyloidosis
  • Melphalan
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Relapsed/Refractory Multiple Myeloma Trial in United States (Ipilimumab)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Jan 21, 2022

Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Stanford (biological, drug,

Completed
Has Results
  • Acute Myeloid Leukemia
  • +6 more
  • Anti-Thymocyte Globulin
  • +5 more
  • Stanford, California
    Stanford University, School of Medicine
Jun 1, 2021

Myeloma, Plasma-Cell, Myeloma-Multiple, Myelomatosis Trial in Bethesda, Hackensack (Adoptive Immunotherapy, Rapamycin-Generated

Terminated
Has Results
  • Myeloma, Plasma-Cell
  • +2 more
  • Adoptive Immunotherapy
  • +2 more
  • Bethesda, Maryland
  • +1 more
Dec 3, 2019

Lymphoma, Mantle-Cell Trial in Stanford (biological, procedure, drug)

Completed
Has Results
  • Lymphoma, Mantle-Cell
  • CpG-MCL vaccine
  • +7 more
  • Stanford, California
    Stanford University Medical Center
Jan 8, 2020

Weight Loss Trial in Chicago (12 Telephone Coaching Sessions, 24 Telephone Coaching Sessions, Report to Primary Care Physician)

Completed
Has Results
  • Weight Loss
  • 12 Telephone Coaching Sessions
  • +5 more
  • Chicago, Illinois
    Northwestern University
Jan 12, 2023

Multiple Myeloma Trial in Memphis, Nashville (VELCADE, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Memphis, Tennessee
  • +1 more
Apr 15, 2018

Plasma Cell Myeloma, Multiple Myeloma Trial run by the NCI (Filgrastim, Plerixafor, Apheresis)

Completed
Has Results
  • Plasma Cell Myeloma
  • Multiple Myeloma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 6, 2018

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte, New York (brentuximab vedotin)

Completed
Has Results
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • brentuximab vedotin
  • Duarte, California
  • +1 more
Mar 28, 2018

Multiple Myeloma, Leukemia, Plasma Cell Trial run by the NCI (Carfilzomib, Melphalan, Filgrastim)

Terminated
Has Results
  • Multiple Myeloma
  • Leukemia, Plasma Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 2, 2016

Transplantation, Homologous, Transplantation, Autologous, Multiple Myeloma Trial in Stanford (procedure, drug, radiation,

Completed
Has Results
  • Transplantation, Homologous
  • +3 more
  • Autologous peripheral blood stem cells (auto-PBSC) transplantation
  • +12 more
  • Stanford, California
    Stanford University School of Medicine
Sep 19, 2017